MedPath

Prospective Study on relationship between CD73 expression in biliary tract cancer and response to anticancer drugs and the underlying biological mechanisms

Not Applicable
Recruiting
Conditions
Biliary tract cancer
Registration Number
JPRN-UMIN000051856
Lead Sponsor
Hokkaido University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients diagnosed as having another malignancy within the past 3 years 2) Patients deemed inappropriate by the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relationship between CD73 expression in the biliary tract cancer specimen and response to anticancer therapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath